Loading clinical trials...
Loading clinical trials...
The primary objective of this study is to evaluate the effect of symptomatic therapies on gastrointestinal (GI)-related events reported by participants with relapsing forms of multiple sclerosis (MS) ...
Bring this clarity to your next appointment.
Keep all your medical notes and next steps in one place.
Lead Sponsor
Biogen
NCT06681623 · Multiple Sclerosis, Relapsing Forms of Multiple Sclerosis
NCT06251986 · Relapsing Forms of Multiple Sclerosis
NCT05083923 · Relapsing Forms of Multiple Sclerosis
NCT04676555 · Relapsing Forms of Multiple Sclerosis
NCT01201356 · Relapsing Forms of Multiple Sclerosis
Research Site
Cullman, Alabama
Research Site
Gilbert, Arizona
Research Site
Scottsdale, Arizona
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions